🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSwitzerland BAG coverage — 12 month update Page 2

Switzerland BAG coverage — 12 month update

SarahChen_PharmD Mon, Feb 2, 2026 at 5:10 PM 29 replies 1,533 viewsPage 2 of 6
PurityPaulOR
Senior Member
1,890
7,890
Mar 2024
Oregon
Feb 2, 2026 at 6:39 PM#6
Dr.LipidDallas said:
Financial impact of cost and coverage weight loss beyond medication cost: Groceries: SAVED $206/month (eating less) Restaurants: SAVED $196/month…

This is where I part company with the consensus forming above. The affordability discussion here usually stops at individual tactics. At list price this class is out of reach for most of the people who would benefit, and no amount of appeal strategy changes that — it is a pricing problem wearing a paperwork costume.

17 12Dr.LeslieOBGYN, MikeNYC_runner and 14 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Feb 2, 2026 at 7:13 PM#7
SarahChen_PharmD said:
Denied on prior authorisation twice, approved on the third attempt after a peer-to-peer, and the only thing that changed was who was doing the…

Insurance coverage hack for cost and coverage: if your insurance denies brand Wegovy/Ozempic, consider these alternatives:

  1. Prior authorization appeal with peer-to-peer review
  2. Manufacturer copay card (for commercial insurance)
  3. Patient assistance programs (Novo Nordisk, Eli Lilly)
  4. Compounded medication from a 503B pharmacy ($102/month)
  5. Canadian pharmacy (requires prescription, ~40-60% savings)

Don't let cost prevent access to effective treatment. There are options at every price point.

16 11tom_AK, josh_phd_bmore, roxy_nash and 13 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Feb 2, 2026 at 7:47 PM#8
PurityPaulOR said:
The affordability discussion here usually stops at individual tactics.

Insurance update relevant to cost and coverage: I just got my prior auth approved through Cigna after 4 attempts.

What finally worked: a letter from my endocrinologist documenting BMI history (>3 years), failed diet attempts, comorbidities (NAFLD + metabolic syndrome), and referencing the STEP trial data.

If your PA keeps getting denied, don't give up. Request a peer-to-peer review between your doctor and the insurance medical director. That's what finally broke through for me.

Last edited: Feb 3, 2026 at 1:47 AM
15 10RunnerRach, TrialNerd_Beth, HPLC_Greg and 12 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Feb 2, 2026 at 8:21 PM#9

Following on from raj_cambridge — and this may be the naive question:

What would you measure differently if you were starting again?

14 9laura_annarbor, JenMemphis, pat_auckland and 11 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Feb 2, 2026 at 11:04 PM#10

Closing the loop on my own question.

Update: approved on the third attempt after a peer-to-peer. Nothing about my case changed; only who was doing the talking.

44 17robert_kc, dan_philly, MeganSA_TX and 41 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register